Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Inhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha1 H101R) with a diazepam-insensitive alpha1 subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha1 subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, α 1-containing GABAA receptors probably mediate the sedative, amnesic, and anticonvulsant actions of classical benzodiazepines [13, 23].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [23]
Citations
Cites
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Wisden, W., Laurie, D., Monyer, H., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01040.1992 · Cited by 1,543
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Essential functions of synapsins I and II in synaptic vesicle regulation
Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719
Self-citationType I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected Cells
Pritchett, D. B., Lüddens, H., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2551039 · Cited by 717
Laurie, D., Seeburg, P., & Wisden, W. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01063.1992 · Cited by 667
Research works printed but not linked: 2
- Barnard, E. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
- Sieghart, W. Structure and function of γ-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47, 181–234 (1995).
Cited by
Olsen, R. W., & Sieghart, W. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00505 · Cited by 1,064
GABAA receptors: Subtypes provide diversity of function and pharmacology
Olsen, R. W., & Sieghart, W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.045 · Cited by 982
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Structure, Function, and Modulation of GABAA Receptors
Sigel, E., & Steinmann, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.386664 · Cited by 812
Molecular and neuronal substrates for general anaesthetics
Rudolph, U., & Antkowiak, B. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1496 · Cited by 772
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Rudolph, U., & Knoflach, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3502 · Cited by 733
A new benzodiazepine pharmacology
Möhler, H., Fritschy, J. M., & Rudolph, U. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.2 · Cited by 716
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703
Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05572.2002 · Cited by 628
Self-citationThe GABA system in anxiety and depression and its therapeutic potential
Möhler, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.040 · Cited by 590
Jurd, R., Arrasa, M., Lambert, S., Drexler, B., Siegwart, R., Crestani, F., Zaugg, M., Vogt, K. E., Ledermann, B., Antkowiak, B., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0611fje · Cited by 558
Rudolph, U., & Möhler, H. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121429 · Cited by 519
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
Drug interactions at GABAA receptors
Korpi, E. R., Gründer, G., & Lüddens, H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00013-8 · Cited by 473
GABAA receptor subtypes: dissecting their pharmacological functions
Rudolph, U., Crestani, F., & Möhler, H. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01646-1 · Cited by 471
Constructing inhibitory synapses
Moss, S. J., & Smart, T. G. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067500 · Cited by 466
GABA system dysfunction in autism and related disorders: From synapse to symptoms
Coghlan, S., Horder, J., Inkster, B., Mendez, M. A., Murphy, D. G., & Nutt, D. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.005 · Cited by 446
Reversal of pathological pain through specific spinal GABAA receptor subtypes
Knabl, J., Witschi, R., Hösl, K., Reinold, H., Zeilhofer, U. B., Ahmadi, S., Brockhaus, J., Sergejeva, M., Hess, A., Brune, K., et al. (2008) · Nature · doi:10.1038/nature06493 · Cited by 438
GABAA receptors: structure, function, pharmacology, and related disorders
Ghit, A., Assal, D., Al-Shami, A. S., & Hussein, D. E. E. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00224-0 · Cited by 405
Neural bases for addictive properties of benzodiazepines
Tan, K. R., Brown, M., Labouèbe, G., Yvon, C., Creton, C., Fritschy, J.-M., Rudolph, U., & Lüscher, C. (2010) · Nature · doi:10.1038/nature08758 · Cited by 397
Fast Synaptic Inhibition in Spinal Sensory Processing and Pain Control
Zeilhofer, H. U., Wildner, H., & Yévenes, G. E. (2012) · Physiological Reviews · doi:10.1152/physrev.00043.2010 · Cited by 371
Hooked on benzodiazepines: GABAA receptor subtypes and addiction
Tan, K. R., Rudolph, U., & Lüscher, C. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.01.004 · Cited by 365
GABAA receptor diversity and pharmacology
Möhler, H. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0284-3 · Cited by 363
GABAA receptor: Positive and negative allosteric modulators
Olsen, R. W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.036 · Cited by 354
Diverse mechanisms of antiepileptic drugs in the development pipeline
Rogawski, M. A. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.02.004 · Cited by 340
Sonner, J. M., Antognini, J. F., Dutton, R. C., Flood, P., Gray, A. T., Harris, R. A., Homanics, G. E., Kendig, J., Orser, B., Raines, D. E., et al. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000081063.76651.33 · Cited by 328
GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?
Whiting, P. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02703-x · Cited by 326
Self-citationShumyatsky, G. P., Tsvetkov, E., Malleret, G., Vronskaya, S., Hatton, M., Hampton, L., Battey, J. F., Dulac, C., Kandel, E. R., & Bolshakov, V. Y. (2002) · Cell · doi:10.1016/s0092-8674(02)01116-9 · Cited by 326
Fritschy, J.-M., & Brünig, I. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00037-8 · Cited by 324
Cagetti, E., Liang, J., Spigelman, I., & Olsen, R. W. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.53 · Cited by 320
Rudolph, U., & Möhler, H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135947 · Cited by 319
Sedation and Anesthesia Mediated by Distinct GABA A Receptor Isoforms
Reynolds, D. S., Rosahl, T. W., Cirone, J., O'Meara, G. F., Haythornthwaite, A., Newman, R. J., Myers, J., Sur, C., Howell, O., Rutter, A. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08608.2003 · Cited by 318
Self-citationStructure, Pharmacology, and Function of GABAA Receptor Subtypes
Sieghart, W. (2006) · Advances in Pharmacology · doi:10.1016/s1054-3589(06)54010-4 · Cited by 317
Ion Channels as Therapeutic Targets: A Drug Discovery Perspective
Bagal, S. K., Brown, A. D., Cox, P. J., Omoto, K., Owen, R. M., Pryde, D. C., Sidders, B., Skerratt, S. E., Stevens, E. B., Storer, R. I., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3011433 · Cited by 316
Alcohol-induced motor impairment caused by increased extrasynaptic GABAA receptor activity
Hanchar, H. J., Dodson, P. D., Olsen, R. W., Otis, T. S., & Wallner, M. (2005) · Nature Neuroscience · doi:10.1038/nn1398 · Cited by 307
Mechanism of action of the hypnotic zolpidem in vivo
Crestani, F., Martin, J. R., Möhler, H., & Rudolph, U. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703717 · Cited by 307
The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
Braat, S., & Kooy, R. F. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.042 · Cited by 294
Lewis, D. A., Cho, R. Y., Carter, C. S., Eklund, K., Forster, S., Kelly, M. A., & Montrose, D. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030395 · Cited by 292
Gebauer, D. L., Pagnussat, N., Piato, Â. L., Schaefer, I. C., Bonan, C. D., & Lara, D. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.021 · Cited by 289
Lüscher, B., & Keller, C. A. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.003 · Cited by 284
Increased anxiety and synaptic plasticity in estrogen receptor β-deficient mice
Krȩżel, W., Dupont, S., Krust, A., Chambon, P., & Chapman, P. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221451898 · Cited by 278
Residual Effects of Hypnotics: Epidemiology and Clinical Implications
Vermeeren, A. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00003 · Cited by 277
GABAA Receptor Channel Pharmacology
Johnston, G. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054021024 · Cited by 274
Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent
Kilpatrick, G. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690875 · Cited by 262
Tests of unconditioned anxiety — Pitfalls and disappointments
Ennaceur, A. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.05.032 · Cited by 259
Generating diversity at GAB Aergic synapses
Cherubini, E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01724-0 · Cited by 256
Lewis, D., Volk, D., & Hashimoto, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1673-x · Cited by 253
“…appear to differentially determine the effects of benzodiazepines, with the sedative effects mediated by the a1 subtype (Rudolph et al. 1999; McKernan et al. 2000), anxiolytic effects mediated by the a2 subtype (L w et al. 2000), and hippocampal learning and memory influenced by the a5…”
BackgroundDias, R., Sheppard, W. F. A., Fradley, R. L., Garrett, E. M., Stanley, J. L., Tye, S. J., Goodacre, S., Lincoln, R. J., Cook, S. M., Conley, R., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1166-05.2005 · Cited by 247
“The GABAA receptor 2H101R knock-in mice were generated similar to the 1H101R mice (McKernan et al., 2000).”
BackgroundMethodInfluentialSelf-citationEvidence for a Common Binding Cavity for Three General Anesthetics within the GABAAReceptor
Jenkins, A., Greenblatt, E. P., Faulkner, H. J., Bertaccini, E., Light, A., Lin, A., Andreasen, A., Viner, A., Trudell, J. R., & Harrison, N. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-j0002.2001 · Cited by 244
Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms
Walters, R. J., Hadley, S. H., Morris, K. D. W., & Amin, J. (2000) · Nature Neuroscience · doi:10.1038/81800 · Cited by 243
Gulinello, M., Gong, Q. H., Li, X., & Smith, S. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02565-3 · Cited by 243
An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition
Dawson, G. R., Maubach, K. A., Collinson, N., Cobain, M., Everitt, B. J., MacLeod, A. M., Choudhury, H. I., McDonald, L. M., Pillai, G., Rycroft, W., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092320 · Cited by 241
Self-citationGeneral Anesthetic Actions on GABAA Receptors
Garcia, P., Kolesky, S., & Jenkins, A. (2010) · Current Neuropharmacology · doi:10.2174/157015910790909502 · Cited by 241
Klausberger, T., Roberts, J. D. B., & Somogyi, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02513.2002 · Cited by 238
Guscott, M., Bristow, L. J., Hadingham, K., Rosahl, T. W., Beer, M. S., Stanton, J. A., Bromidge, F., Owens, A. P., Huscroft, I., Myers, J., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.015 · Cited by 231
Self-citationDiazepam-induced changes in sleep: Role of the α1 GABAAreceptor subtype
Tobler, I., Kopp, C., Deboer, T., & Rudolph, U. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111055398 · Cited by 230
Loss of the Major GABAAReceptor Subtype in the Brain Is Not Lethal in Mice
Sur, C., Wafford, K. A., Reynolds, D. S., Hadingham, K. L., Bromidge, F., Macaulay, A., Collinson, N., O'Meara, G., Howell, O., Newman, R., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03409.2001 · Cited by 229
Self-citationRowlett, J. K., Platt, D. M., Lelas, S., Atack, J. R., & Dawson, G. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405621102 · Cited by 212
Self-citationSieghart, W., & Savić, M. M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014449 · Cited by 210
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABAA receptor subtypes
Sanna, E., Busonero, F., Talani, G., Carta, M., Massa, F., Peis, M., Maciocco, E., & Biggio, G. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02191-x · Cited by 208
Molecular mechanisms of antiseizure drug activity at GABAA receptors
Greenfield, L. J. (2013) · Seizure · doi:10.1016/j.seizure.2013.04.015 · Cited by 206
Bianchi, M. T., & Macdonald, R. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10934.2003 · Cited by 206
Victorri‐Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02861.x · Cited by 201
Yee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201
The glycinergic control of spinal pain processing
Zeilhofer, H. U. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5107-2 · Cited by 200
Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond
Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 197
Nyíri, G., Freund, T. F., & Somogyi, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01407.x · Cited by 197
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“Specifically, α1-containing GABAA receptors probably mediate the sedative, amnesic, and anticonvulsant actions of classical benzodiazepines [13, 23].”
BackgroundAtack, J. R. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.601 · Cited by 192
Self-citationGABAA receptors: structure and function in the basal ganglia
Goetz, T., Arslan, A., Wisden, W., & Wulff, P. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(06)60003-4 · Cited by 146
Lanctôt, K. L., Herrmann, N., Mazzotta, P., Khan, L. R., & Ingber, N. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900705 · Cited by 191
Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome
Ng, Y. T., Conry, J. A., Drummond, R., Stolle, J., & Weinberg, M. A. (2011) · Neurology · doi:10.1212/wnl.0b013e318232de76 · Cited by 191
Cutler, A. J., Mattingly, G. W., & Maletic, V. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02514-2 · Cited by 192
Atack, J. R., Wafford, K. A., Tye, S. J., Cook, S. M., Sohal, B., Pike, A., Sur, C., Melillo, D., Bristow, L., Bromidge, F., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089920 · Cited by 188
Self-citationThe Role of GABA Receptor Agonists in Anesthesia and Sedation
Brohan, J., & Goudra, B. G. (2017) · CNS Drugs · doi:10.1007/s40263-017-0463-7 · Cited by 183
GABAA Receptors: Subtypes, Regional Distribution, and Function
Nutt, D. J. (2006) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26525 · Cited by 180
The complexity of the GABAA receptor shapes unique pharmacological profiles
D’Hulst, C., Atack, J. R., & Kooy, R. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.06.009 · Cited by 178
Self-citationNeurosteroids, GABAA receptors, and escalated aggressive behavior
Miczek, K. A., Fish, E. W., & De Bold, J. F. (2003) · Hormones and Behavior · doi:10.1016/j.yhbeh.2003.04.002 · Cited by 177
The Vogel conflict test: procedural aspects, γ-aminobutyric acid, glutamate and monoamines
Millan, M. J., & Brocco, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01275-5 · Cited by 177
Correction of respiratory disorders in a mouse model of Rett syndrome
Abdala, A. P. L., Dutschmann, M., Bissonnette, J. M., & Paton, J. F. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012104107 · Cited by 174
Nguyen, N., Fakra, E., Pradel, V., Jouve, E., Alquier, C., Le Guern, M., Micallef, J., & Blin, O. (2006) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.757 · Cited by 143
γ-Aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions
Boehm, S. L., Ponomarev, I., Jennings, A. W., Whiting, P. J., Rosahl, T. W., Garrett, E. M., Blednov, Y. A., & Harris, R. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.023 · Cited by 173
Self-citationHypnosedative-Induced Complex Behaviours: Incidence, Mechanisms and Management
Dolder, C. R., & Nelson, M. H. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00005 · Cited by 172
Prenosil, G. A., Schneider Gasser, E. M., Rudolph, U., Keist, R., Fritschy, J.-M., & Vogt, K. E. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01199.2005 · Cited by 171
Kralic, J. E., O’Buckley, T. K., Khisti, R. T., Hodge, C. W., Homanics, G. E., & Morrow, A. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00174-0 · Cited by 168
Molecular targets in the treatment of anxiety
Kent, J. M., Mathew, S. J., & Gorman, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01672-4 · Cited by 167
RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors
Ballard, T. M., Knoflach, F., Prinssen, E. P. M., Borroni, E., Vivian, J. A., Basile, J., Gasser, R., Moreau, J., Wettstein, J. G., Buettelmann, B., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1357-7 · Cited by 167
Treating insomnia: Current and investigational pharmacological approaches
Ebert, B., Wafford, K. A., & Deacon, S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.014 · Cited by 166
Self-citationGenetic animal models of anxiety
Finn, D. A., Rutledge-Gorman, M. T., & Crabbe, J. C. (2003) · Neurogenetics · doi:10.1007/s10048-003-0143-2 · Cited by 166
The GABAA receptor: a novel target for treatment of fragile X?
D’Hulst, C., & Kooy, R. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.003 · Cited by 166
GABA Receptors: Pharmacological Potential and Pitfalls
Jembrek, M., & Vlainic, J. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150914121624 · Cited by 164
Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics
Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106927 · Cited by 163
Chronic Pain States: Pharmacological Strategies to Restore Diminished Inhibitory Spinal Pain Control
Zeilhofer, H. U., Benke, D., & Yevenes, G. E. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134636 · Cited by 162
Gaboxadol — a new awakening in sleep
Wafford, K. A., & Ebert, B. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.004 · Cited by 162
Self-citationNeuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence
Allison, C., & Pratt, J. A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00029-9 · Cited by 160
Chuang, S.-H., & Reddy, D. S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244673 · Cited by 160
Molecular regulation of cognitive functions and developmental plasticity: impact of GABAAreceptors
Möhler, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04454.x · Cited by 133
Role of GABAAreceptors in the physiology and pharmacology of sleep
Winsky‐Sommerer, R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06716.x · Cited by 144
Identification of a Novel, Selective GABAAα5 Receptor Inverse Agonist Which Enhances Cognition
Chambers, M. S., Atack, J. R., Broughton, H. B., Collinson, N., Cook, S., Dawson, G. R., Hobbs, S. C., Marshall, G., Maubach, K. A., Pillai, G. V., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020582q · Cited by 139
Self-citation
Metadata
- Authors
- McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., Garrett, L., Bristow, L., Marshall, G., Macaulay, A., Brown, N., Howell, O., Moore, K. W., Carling, R. W., Street, L. J., Castro, J. L., Ragan, C. I., Dawson, G. R., & Whiting, P. J.
- Affiliations
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- McKernan, R. M.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2000-06
- Volume
- 3
- Issue
- 6
- Pages
- 587-592
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2001619275
- Cited by
- 944
- References
- 35
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 18 · 2023: 23 · 2022: 14 · 2021: 23 · 2020: 30 · 2019: 24 · 2018: 37 · 2017: 22 · 2016: 30 · 2015: 29 · 2014: 32 · 2013: 36 · 2012: 37
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, sedation, anxiolytic effects, genetically modified mice, inhibitory neurotransmission, diazepam
- MeSH terms
- Allosteric Site, Animals, Anticonvulsants, Azides, Benzodiazepines, Binding, Competitive, Brain, Cell Line, Diazepam, Dose-Response Relationship, Drug, Flumazenil, Fluorobenzenes, Hypnotics and Sedatives, Ligands, Mice, Inbred C57BL, Mice, Mutant Strains, Motor Activity, Receptors, GABA-A, Reflex, Startle, Anti-Anxiety Agents, Triazoles, Patch-Clamp Techniques, Mice, GABA-A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.